Assignee
AMGEN INC
US·1,642 granted patents·958 pending applications·35,470 citations·filing 1984–2025
Top patents by PatentIndex Score
2,600 records- 0199USD1001272SAutoinjector with removable capAMGEN INC·Filed 2021·Granted Oct 10, 2023·37 cites·1 claims
- 0299USD922567SAutoinjector with removable capAMGEN INC·Filed 2020·Granted Jun 15, 2021·43 cites·1 claims
- 0399USD898189SAutoinjector with removable capAMGEN INC·Filed 2020·Granted Oct 6, 2020·50 cites·1 claims
- 0499US8859741B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Oct 14, 2014·51 cites·24 claims
- 0599US8829165B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2013·Granted Sep 9, 2014·76 cites·29 claims
- 0699US8030457B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2008·Granted Oct 4, 2011·175 cites·27 claims
- 0799US7915391B2Humanized c-Kit antibodyAMGEN INC·Filed 2007·Granted Mar 29, 2011·112 cites·10 claims
- 0898US11993597B2Inhibitors of KRAS G12C and methods of using the sameAMGEN INC·Filed 2022·Granted May 28, 2024·8 cites·50 claims
- 0998US11905281B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2020·Granted Feb 20, 2024·13 cites·16 claims
- 1098US11766436B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2021·Granted Sep 26, 2023·11 cites·19 claims
- 1198US11306087B2Inhibitors of KRAS G12C and methods of using the sameAMGEN INC·Filed 2020·Granted Apr 19, 2022·16 cites·55 claims
- 1298US11090304B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2019·Granted Aug 17, 2021·33 cites·3 claims
- 1398US10640504B2Inhibitors of KRAS G12C and methods of using the sameAMGEN INC·Filed 2018·Granted May 5, 2020·50 cites·71 claims
- 1498USD878560SAutoinjector with removable capAMGEN INC·Filed 2018·Granted Mar 17, 2020·59 cites·1 claims
- 1598US10532042B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2017·Granted Jan 14, 2020·49 cites·13 claims
- 1698US10519146B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2018·Granted Dec 31, 2019·81 cites·33 claims
- 1798US10344016B2Bromotriazole intermediatesAMGEN INC·Filed 2018·Granted Jul 9, 2019·8 cites·5 claims
- 1898USD851754SAutoinjector with removable capAMGEN INC·Filed 2018·Granted Jun 18, 2019·69 cites·1 claims
- 1998USD819198SAutoinjector with removable capAMGEN INC·Filed 2016·Granted May 29, 2018·80 cites·1 claims
- 2098USD814022SAutoinjector with removable capAMGEN INC·Filed 2016·Granted Mar 27, 2018·83 cites·1 claims
- 2198US9842408B2Methods and apparati for nondestructive detection of undissolved particles in a fluidAMGEN INC·Filed 2016·Granted Dec 12, 2017·29 cites·12 claims
- 2298US9573936B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Feb 21, 2017·19 cites·56 claims
- 2398US8999917B2Variant activin receptor polypeptides and uses thereofAMGEN INC·Filed 2013·Granted Apr 7, 2015·48 cites·19 claims
- 2498US8883983B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Nov 11, 2014·26 cites·30 claims
- 2598US8871914B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Oct 28, 2014·26 cites·25 claims
- 2698US8871913B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Oct 28, 2014·26 cites·29 claims
- 2798US8361963B2Uses of FGF21 polypeptides comprising two or more mutationsAMGEN INC·Filed 2011·Granted Jan 29, 2013·64 cites·4 claims
- 2898US8034770B2FGF21 polypeptides comprising two or more mutationsAMGEN INC·Filed 2009·Granted Oct 11, 2011·63 cites·15 claims
- 2998US7879323B2Antibodies to fibroblast growth factor-like polypeptidesAMGEN INC·Filed 2008·Granted Feb 1, 2011·45 cites·12 claims
- 3098US7767206B2Neutralizing determinants of IL-17 Receptor A and antibodies that bind theretoAMGEN INC·Filed 2007·Granted Aug 3, 2010·76 cites·8 claims
- 3198US7667008B2Fibroblast growth factor-like polypeptides and variants thereofAMGEN INC·Filed 2007·Granted Feb 23, 2010·65 cites·19 claims
- 3298US7442778B2Modified Fc moleculesAMGEN INC·Filed 2005·Granted Oct 28, 2008·140 cites·14 claims
- 3398US7364736B2Antibodies to OPGLAMGEN INC·Filed 2002·Granted Apr 29, 2008·97 cites·25 claims
- 3498US7282504B2Kinase inhibitorsAMGEN INC·Filed 2005·Granted Oct 16, 2007·90 cites·11 claims
- 3598US7138370B2Specific binding agents of human angiopoietin-2AMGEN INC·Filed 2002·Granted Nov 21, 2006·100 cites·25 claims
- 3698US6919426B2Peptides and related molecules that modulate nerve growth factor activityAMGEN INC·Filed 2003·Granted Jul 19, 2005·256 cites·3 claims
- 3798US6660843B1Modified peptides as therapeutic agentsAMGEN INC·Filed 1999·Granted Dec 9, 2003·631 cites·10 claims
- 3898US6096728AComposition and method for treating inflammatory diseasesAMGEN INC·Filed 1997·Granted Aug 1, 2000·322 cites·20 claims
- 3998US5824784AN-terminally chemically modified protein compositions and methodsAMGEN INC·Filed 1994·Granted Oct 20, 1998·779 cites·12 claims
- 4097US12102808B2Drug delivery deviceAMGEN INC·Filed 2020·Granted Oct 1, 2024·12 cites·17 claims
- 4197USD1023290SAutoinjector with removable capAMGEN INC·Filed 2023·Granted Apr 16, 2024·13 cites·1 claims
- 4297USD985119SHandheld drug delivery deviceAMGEN INC·Filed 2021·Granted May 2, 2023·47 cites·1 claims
- 4397USD974547SHandheld drug delivery deviceAMGEN INC·Filed 2020·Granted Jan 3, 2023·54 cites·1 claims
- 4497USD973866SHandheld drug delivery deviceAMGEN INC·Filed 2020·Granted Dec 27, 2022·48 cites·1 claims
- 4597USD958329SHandheld drug delivery deviceAMGEN INC·Filed 2020·Granted Jul 19, 2022·64 cites·1 claims
- 4697US11298463B2Method of assembling and filling a drug delivery deviceAMGEN INC·Filed 2020·Granted Apr 12, 2022·6 cites·25 claims
- 4797US11285135B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2019·Granted Mar 29, 2022·20 cites·16 claims
- 4897US11096939B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2019·Granted Aug 24, 2021·24 cites·30 claims
- 4997US11045484B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2019·Granted Jun 29, 2021·24 cites·34 claims
- 5097US10988485B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2019·Granted Apr 27, 2021·27 cites·51 claims
Showing the top 50 of 2,600 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →